Vanda Pharmaceuticals
VNDA
#7642
Rank
โ‚ฌ0.34 B
Marketcap
5,83ย โ‚ฌ
Share price
0.74%
Change (1 day)
49.77%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚ฌ0.11 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2024 the company made an earning of -โ‚ฌ34.72 Million a decrease over its 2023 earnings that were of -โ‚ฌ11.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.11 Billion208.61%
2024 -โ‚ฌ34.72 Million191.43%
2023 -โ‚ฌ11.92 Million-320.45%
2022 โ‚ฌ5.4 M-84.99%
2021 โ‚ฌ35.99 M54.8%
2020 โ‚ฌ23.25 M19.42%
2019 โ‚ฌ19.47 M4.93%
2018 โ‚ฌ18.55 M-228.6%
2017 -โ‚ฌ14.44 Million-8.98%
2016 -โ‚ฌ15.86 Million-53.79%
2015 -โ‚ฌ34.31 Million-30.18%
2014 -โ‚ฌ49.14 Million173.08%
2013 -โ‚ฌ18 Million-25.33%
2012 -โ‚ฌ24.1 Million163.61%
2011 -โ‚ฌ9.15 Million-221.15%
2010 โ‚ฌ7.54 M-124.53%
2009 -โ‚ฌ30.77 Million-29.44%
2008 -โ‚ฌ43.6 Million-36.2%
2007 -โ‚ฌ68.33 Million21.81%
2006 -โ‚ฌ56.1 Million170.55%
2005 -โ‚ฌ20.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.64 B-27,807.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.95 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ8.70 B-8,516.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ21.96 B-21,348.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.14 B-18,617.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ7.96 B-7,803.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.4 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA